SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-001070
Filing Date
2022-02-10
Accepted
2022-02-10 16:01:29
Documents
64
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q meip-20211231.htm   iXBRL 10-Q 1854695
2 EX-31.1 meip-ex31_1.htm EX-31.1 18173
3 EX-31.2 meip-ex31_2.htm EX-31.2 18049
4 EX-32.1 meip-ex32_1.htm EX-32.1 13393
5 GRAPHIC img102239242_0.jpg GRAPHIC 70565
6 GRAPHIC img102239242_1.jpg GRAPHIC 21423
  Complete submission text file 0000950170-22-001070.txt   7909567

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT meip-20211231_lab.xml EX-101.LAB 418282
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT meip-20211231_pre.xml EX-101.PRE 345619
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT meip-20211231.xsd EX-101.SCH 46842
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT meip-20211231_cal.xml EX-101.CAL 37572
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT meip-20211231_def.xml EX-101.DEF 283118
58 EXTRACTED XBRL INSTANCE DOCUMENT meip-20211231_htm.xml XML 1549979
Mailing Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130
Business Address 11455 EL CAMINO REAL SUITE 250 SAN DIEGO CA 92130 858-369-7100
MEI Pharma, Inc. (Filer) CIK: 0001262104 (see all company filings)

IRS No.: 510407811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-50484 | Film No.: 22613830
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences